XML 67 R48.htm IDEA: XBRL DOCUMENT v3.10.0.1
Collaboration Agreements (Royalty Revenues under the Collaboration Agreement with GSK) (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 28, 2018
Dec. 29, 2017
Jan. 01, 2016
Collaborative Arrangements with Glaxo Smith Kline      
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]      
Royalty expense $ 23,950 $ 12,413 $ 4,334
Collaborative Arrangement with GlaxoSmithKline | Collaborative Arrangement with Ipsen      
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]      
Percent of royalty on net sale 3.00%